to compare the level of effectiveness in attaining glycemic control while treating GDM mothers on metformin vs insuli
Phase 3
- Conditions
- Health Condition 1: E139- Other specified diabetes mellituswithout complications
- Registration Number
- CTRI/2023/11/060216
- Lead Sponsor
- Mukul Panda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. To include pregnant female between 24 to 28 weeks pog having 75
gm OGTT more than 140 mg/dl but less than 200 mg/dl patients
Exclusion Criteria
1. Deranged OGTT before 24 weeks of pregnancy
2. Patients diagnosed with MODY (modified onset diabetes in young)
3. Type 1 diabetes
4. Patients who have neuropsychiatric disorder, cardiovascular conditions or other
comorbid conditions
5. Type 2 diabetes
6. GDM control on MNT and exercise
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the degree of glycemic control achieved by treating <br/ ><br>GDM diagnosed patients with metformin vs insulinTimepoint: from 24 to 28 weeks of gestation till delivery
- Secondary Outcome Measures
Name Time Method to compare maternal and fetal outcomesTimepoint: from 24 weeks to 28 weeks of delivery